AIDS patients suffer higher risk of advanced knee osteoarthritis progression due to lopinavir-induced Zmpste24 inhibition

Abstract

Debate regarding the premature aging of knee joints in acquired immune deficiency syndrome (AIDS) patients has remained contentious, with conjectures pointing towards its correlation with distinct antiviral regimes. Protease inhibitors (PIs) stand as a prominent class of antiviral agents frequently utilized in AIDS management and have been significantly linked to premature senescence. This study aimed to investigate whether PI-containing regimens would accelerate osteoarthritis (OA) development and explore the molecular mechanisms underlying this association. A retrospective cohort of 151 HIV-infected individuals, categorized into PI and non-PI groups, was established. Patients in PI group exhibited lower KOOS and a higher prevalence of radiological knee OA than those in non-PI group. Additionally, 25 anti-HIV drugs were screened and among all antiviral drugs, lopinavir had the most detrimental impact on cartilage anabolism, accelerating cartilage senescence and promoting mouse OA development. Mechanistically, lopinavir accelerated cellular senescence by inhibiting Zmpste24 and interfering nuclear membrane stability, which leads to decreased binding between nuclear membrane-binding protein Usp7 and Mdm2 and activates Usp7/Mdm2/p53 pathway. Zmpste24 overexpression reduces OA severity in mice. These findings suggest that PI-containing regimens accelerate cartilage senescence and OA development through Zmpste24 inhibition, which provides new insights into the selection of HIV regimens.

Keywords

Medical and Health Sciences / Clinical Sciences

References

[1] KingLK. Osteoarthritis and comorbidity: time for action. Osteoarthr. Cartil., 2023, 31: 423-424.

[2] PriceJS, et al. . The role of chondrocyte senescence in osteoarthritis. Aging Cell, 2002, 1: 57-65.

[3] FreundA, OrjaloAV, DesprezPY, CampisiJ. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med., 2010, 16: 238-246.

[4] ChenX, et al. . METTL3-mediated m(6)A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression. Ann. Rheum. Dis., 2022, 81: 87-99.

[5] Kong, K. Y. et al. A Ubiquitin-competitive strategy based on the element microenvironment to treat osteoarthritis. Adv. Funct. Mater. 34, 2409707 (2024).

[6] JeonOH, et al. . Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med., 2017, 23: 775-781.

[7] KongK, et al. . Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence. J. Nanobiotechnol., 2025, 23. 34

[8] DeeksSG, LewinSR, HavlirDV. The end of AIDS: HIV infection as a chronic disease. Lancet, 2013, 382: 1525-1533.

[9] NandithaNGA, et al. . Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: a population-based cohort study. BMJ Open, 2021, 11. e041734

[10] FriedmanEE, DuffusWA. Chronic health conditions in Medicare beneficiaries 65 years old, and older with HIV infection. Aids, 2016, 30: 2529-2536.

[11] LiuY, et al. . Is treated HIV infection associated with knee cartilage degeneration and structural changes? A longitudinal study using data from the osteoarthritis initiative. BMC Musculoskelet. Disord., 2019, 20. 190

[12] TomiAL, et al. . Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study. Ann. Rheum. Dis., 2016, 75: 2101-2107.

[13] WangKD, et al. . Digoxin targets low density lipoprotein receptor-related protein 4 and protects against osteoarthritis. Ann. Rheum. Dis., 2022, 81: 544-555.

[14] KongK, et al. . Paxlovid accelerates cartilage degeneration and senescence through activating endoplasmic reticulum stress and interfering redox homeostasis. J. Transl. Med., 2022, 20. 549

[15] DelpinoMV, QuarleriJ. Influence of HIV infection and antiretroviral therapy on bone homeostasis. Front. Endocrinol., 2020, 11: 502.

[16] Hernandez-VallejoSJ, et al. . HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatin. Aging Cell, 2013, 12: 955-965.

[17] WakabayashiY, et al. . Inhibition of osteoblast differentiation by ritonavir. Biomed. Rep., 2018, 9: 491-496

[18] SantiagoF, OgumaJ, BrownAM, LaurenceJ. Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir. Biochem. Biophys. Res. Commun., 2012, 417: 223-230.

[19] YinMT, et al. . Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal women. Osteoporos. Int., 2011, 22: 1459-1468.

[20] HoyJF, et al. . Immediate initiation of antiretroviral therapy for HIV infection accelerates bone loss relative to deferring therapy: findings from the START bone mineral density substudy, a randomized trial. J. Bone Miner. Res., 2017, 32: 1945-1955.

[21] ChiuML, et al. . Timing, dosage, and adherence of antiretroviral therapy and risk of osteoporosis in patients with human immunodeficiency virus infection in Taiwan: a nested case-control study. Front. Pharm., 2021, 12: 631480.

[22] AfonsoP, et al. . LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: role of ZMPSTE24 downregulation. Atherosclerosis, 2016, 245: 200-211.

[23] RagnauthCD, et al. . Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation, 2010, 121: 2200-2210.

[24] QuigleyA, et al. . The structural basis of ZMPSTE24-dependent laminopathies. Science, 2013, 339: 1604-1607.

[25] CoffinierC, et al. . HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. Proc. Natl. Acad. Sci. USA, 2007, 104: 13432-13437.

[26] MehmoodS, et al. . Mass spectrometry captures off-target drug binding and provides mechanistic insights into the human metalloprotease ZMPSTE24. Nat. Chem., 2016, 8: 1152-1158.

[27] CoffinierC, et al. . A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells. J. Biol. Chem., 2008, 283: 9797-9804.

[28] WormanHJ, OstlundC, WangY. Diseases of the nuclear envelope. Cold Spring Harb. Perspect. Biol., 2010, 2. a000760

[29] MoulsonCL, et al. . Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy. J. Investig. Dermatol., 2005, 125: 913-919.

[30] BergoMO, et al. . Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc. Natl. Acad. Sci. USA, 2002, 99: 13049-13054.

[31] MahmoudianA, et al. . Early-stage symptomatic osteoarthritis of the knee—time for action. Nat. Rev. Rheumatol., 2021, 17: 621-632.

[32] HayashiD, RoemerFW, JarrayaM, GuermaziA. Imaging in osteoarthritis. Radio. Clin. North Am., 2017, 55: 1085-1102.

[33] RunhaarJ, et al. . Towards developing diagnostic criteria for early knee osteoarthritis: data from the CHECK study. Rheumatology, 2021, 60: 2448-2455.

[34] SuoJ, et al. . Accelerated aging in articular cartilage by ZMPSTE24 deficiency leads to osteoarthritis with impaired metabolic signaling and epigenetic regulation. Cell Death Dis., 2023, 14. 336

[35] ThompsonSD, PichikaR, LieberRL, LavasaniM. Systemic transplantation of adult multipotent stem cells prevents articular cartilage degeneration in a mouse model of accelerated ageing. Immun. Ageing, 2021, 18: 27.

[36] López-Alonso, I. et al. Preventing loss of mechanosensation by the nuclear membranes of alveolar cells reduces lung injury in mice during mechanical ventilation. Sci. Transl. Med. 10, eaam7598 (2018).

[37] VarelaI, et al. . Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature, 2005, 437: 564-568.

[38] LiuB, et al. . Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria. Cell Metab., 2012, 16: 738-750.

[39] LiuB, et al. . Depleting the methyltransferase Suv39h1 improves DNA repair and extends lifespan in a progeria mouse model. Nat. Commun., 2013, 4. 1868

[40] AoY, et al. . Lamin A buffers CK2 kinase activity to modulate aging in a progeria mouse model. Sci. Adv., 2019, 5: eaav5078.

[41] LaneN, et al. . A phase 2, randomized, double-blind, placebo-controlled study of senolytic molecule Ubx0101 in the treatment of painful knee osteoarthritis. Osteoarthr. Cartil., 2021, 29: S52-S53.

[42] KongK, et al. . Mechanical overloading leads to chondrocyte degeneration and senescence via Zmpste24-mediated nuclear membrane instability. iScience, 2023, 26: 108119.

[43] KellgrenJH, LawrenceJS. Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis., 1957, 16: 494-502.

[44] RoosEM, LohmanderLS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual. Life Outcomes, 2003, 1: 64.

[45] SophocleousA, HuesaC. Osteoarthritis mouse model of destabilization of the medial meniscus. Methods Mol. Biol., 2019, 1914: 281-293.

[46] KangD, et al. . Selenophosphate synthetase 1 deficiency exacerbates osteoarthritis by dysregulating redox homeostasis. Nat. Commun., 2022, 13. 779

[47] FaustHJ, et al. . A hyaluronic acid binding peptide-polymer system for treating osteoarthritis. Biomaterials, 2018, 183: 93-101.

[48] KrennV, et al. . Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology, 2006, 49: 358-364.

[49] ZhouF, et al. . Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-κB/MAPK signaling and protecting chondrocytes. Acta Pharm. Sin. B, 2019, 9: 973-985.

[50] GossetM, BerenbaumF, ThirionS, JacquesC. Primary culture and phenotyping of murine chondrocytes. Nat. Protoc., 2008, 3: 1253-1260.

Funding

The Youth Talent Program from Shanghai Health System (2022YQ020)

National Natural Science Foundation of China (National Science Foundation of China)(82472476)

Natural Science Foundation of Shanghai (Natural Science Foundation of Shanghai Municipality)(23ZR1437300)

Fundamental Research Funds for the Central Universities (YG2023ZD15)

RIGHTS & PERMISSIONS

The Author(s)